V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006650 | 300004750 | 1.54 | 44.6 | Curative (C) | 2015-04-27 | 2015-04-27 | Cisplatin + Etoposide po&iv 3 day | N | N | 300017813 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006651 | 300004750 | 1.65 | null | Palliative (P) | 2013-08-02 | 2013-08-08 | Cisplatin +Fluorouracil (2 wk) | Y | N | 300017813 | CISPLATIN + FLUOROURACIL |
| 300006652 | 300004750 | 1.63 | 74 | Palliative (P) | null | 2018-05-20 | Oxaliplatin + Modified de Gramont | N | N | 300017813 | OXALIPLATIN + MDG |
| 300006653 | 300004750 | 2 | 65.1 | null | 2016-03-28 | 2016-12-30 | Trial Unspecified | 02 | null | 300017813 | CARBOPLATIN |
| 300006654 | 300006967 | 1.78 | 115.1 | Curative (C) | 2016-02-16 | 2016-02-17 | Trial Unspecified | 02 | N | 300017829 | CAPECITABINE + GEMCITABINE |
| 300006655 | 300004755 | 1.75 | 108.25 | null | 2015-01-31 | 2015-02-01 | AML 19 TRIAL | N | null | 300017834 | TOPOTECAN |
| 300006656 | 300004755 | 1.57 | 54 | Neo-adjuvant (N) | 2015-10-24 | 2015-11-28 | CETUXIMAB + RT | null | null | 300017834 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006657 | 300004756 | 1.9 | null | Palliative (P) | 2017-04-25 | 2017-04-30 | CETUXIMAB | N | null | 300017844 | OXALIPLATIN + MDG |
| 300006658 | 300004757 | 0 | 58 | Neo-adjuvant (N) | 2017-04-18 | 2017-04-20 | Cetuximab 7 day (Cycle 1) | 2 | N | 300017847 | OXALIPLATIN + MDG |
| 300006659 | 300004758 | 1.87 | 60.4 | Palliative (P) | 2016-01-29 | 2016-02-15 | NAB PACLITAXEL | N | N | 300017852 | CARBOPLATIN + PACLITAXEL |
| 300006660 | 300004759 | 1.81 | 47 | Neo-adjuvant (N) | 2013-03-16 | 2013-07-19 | CAV | null | N | 300017857 | PANITUMUMAB |
| 300006661 | 300004760 | 1.73 | 76.1 | null | 2016-04-07 | 2016-04-15 | Carboplatin AUC 6 - 10 | N | N | 300017859 | GEMCITABINE + NAB-PACLITAXEL |
| 300006662 | 300004760 | 1.57 | null | Neo-adjuvant (N) | 2013-11-06 | 2013-11-11 | Temozolomide 200mg/m2 | Y | N | 300017859 | OXALIPLATIN + MDG |
| 300006663 | 300004761 | 1.67 | 0 | Curative (C) | 2017-10-10 | 2017-10-10 | CISPLATIN + FLUOROURACIL | N | N | 300017870 | CARBOPLATIN + PACLITAXEL |
| 300006664 | 300004761 | 1.65 | 83.6 | Neo-adjuvant (N) | 2017-12-25 | 2018-01-11 | CARBOPLATIN + RT | N | null | 300017870 | CHOP R + LIPOSOMAL DOX |
| 300006665 | 300004762 | null | null | Neo-adjuvant (N) | 2013-05-09 | 2013-05-14 | Trial Unspecified | N | N | 300017878 | OXALIPLATIN + MDG |
| 300006666 | 300004763 | 1.84 | 73.5 | Curative (C) | 2014-05-13 | 2014-06-10 | Cetuximab + Radiotherapy Maint | N | Y | 300017880 | CETUXIMAB + RT |
| 300006667 | 300004763 | 1.75 | null | Palliative (P) | null | 2014-08-27 | CARBOPLATIN + PACLITAXEL | N | N | 300017880 | PACLITAXEL |
| 300006668 | 300004764 | 1.48 | null | Neo-adjuvant (N) | 2017-01-08 | 2017-01-18 | LUX TRIAL | null | null | 300017888 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006669 | 300004765 | 1.72 | 78.1 | Curative (C) | 2017-04-06 | 2017-04-06 | DE-ESCALATE TRIAL | 02 | null | 300017888 | CARBOPLATIN |
| 300006670 | 300004766 | 1.82 | 65.1 | Palliative (P) | null | 2017-01-20 | NIVOLUMAB | 02 | N | 300017894 | CARBO + FLUOROURACIL |
| 300006673 | 300004769 | 1.62 | null | Palliative (P) | 2014-08-17 | 2014-08-29 | Cisplatin | N | Y | 300017904 | CISPLATIN + FLUOROURACIL + RT |
| 300006674 | 300004770 | 1.79 | 86 | Curative (C) | null | 2018-08-02 | Capecitabine | null | null | 300017909 | CETUXIMAB |
| 300006675 | 300004771 | 1.65 | 50.4 | Curative (C) | null | 2017-04-21 | Cetuximab 7 day (>Cycle 2) | null | null | 300017913 | CISPLATIN |
| 300006676 | 300004772 | null | 65.8 | Curative (C) | 2016-11-12 | 2016-11-20 | Cetuximab 7 day (>Cycle 2) | null | Y | 300017916 | GEMCITABINE + RT |
| 300006677 | 300004772 | 1.71 | 81.8 | null | 2015-01-14 | 2015-01-29 | Carboplatin AUC 2 - 5 | N | Y | 300017916 | CISPLATIN |
| 300006678 | 300004773 | 1.81 | 84.4 | Palliative (P) | 2014-05-03 | 2014-05-16 | Carboplatin AUC 6 - 10 | 02 | Y | 300017929 | CETUXIMAB |
| 300006679 | 300004774 | 1.65 | 83.2 | Neo-adjuvant (N) | 2015-07-02 | 2015-07-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300017930 | CISPLATIN |
| 300006680 | 300004775 | 1.85 | 88 | Disease modification (D) | null | 2014-11-23 | Carboplatin AUC 2 - 5 | Y | N | 300017931 | EOX |
| 300006681 | 300006982 | 1.76 | 112 | Neo-adjuvant (N) | 2015-10-30 | 2015-10-31 | NIVOLUMAB | 02 | N | 300017931 | CAPECITABINE |
| 300006684 | 300004777 | 1.63 | 44.6 | Palliative (P) | 2014-06-19 | 2016-01-29 | Oxaliplatin + Modified de Gramont | N | N | 300017947 | FLUOROURACIL |
| 300006685 | 300004782 | 1.77 | 66.4 | Curative (C) | 2017-07-12 | 2017-08-23 | Capecitabine | 02 | null | 300017954 | CAPECITABINE |
| 300006686 | 300004784 | 1.71 | 88.35 | Curative (C) | 2016-07-01 | 2016-10-23 | Cetuximab 7 day (>Cycle 2) | Y | Y | 300017957 | CISPLATIN + FLUOROURACIL + RT |
| 300006687 | 300006985 | 1.54 | 66 | null | 2016-09-14 | 2016-10-09 | Cetuximab 7 day (Cycle 1) | 02 | N | 300017959 | CETUXIMAB |
| 300006688 | 300006985 | 1.77 | 57.2 | Palliative (P) | 2013-06-29 | 2013-09-25 | Gemcitabine + Capecitabine | 02 | N | 300017959 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006689 | 300006985 | 1.49 | 71.8 | Palliative (P) | 2018-07-16 | 2018-07-16 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300017959 | CETUXIMAB |
| 300006690 | 300008330 | 1.59 | 75.8 | Curative (C) | 2014-09-07 | 2014-09-20 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | Y | 300017979 | CETUXIMAB + RT |
| 300006691 | 300008350 | 1.71 | 49.7 | Neo-adjuvant (N) | 2017-08-15 | 2017-08-25 | BENDAMUSTINE | N | N | 300017984 | CARBOPLATIN |
| 300006692 | 300004785 | null | 99 | Neo-adjuvant (N) | 2015-06-30 | 2015-07-27 | CETUXIMAB | 02 | N | 300017986 | OXALIPLATIN + MDG |
| 300006693 | 300004785 | 1.6 | 90 | null | 2014-07-02 | 2014-07-03 | Carboplatin + Cetux + FU (Cycle 1) | 2 | N | 300017986 | CARBOPLATIN + VINORELBINE |
| 300006694 | 300004785 | 1.53 | 62 | Curative (C) | 2016-11-07 | 2016-11-21 | Cisplatin + Fluorouracil + RT 5day | 2 | Y | 300017986 | CAPECITABINE |
| 300006695 | 300008274 | 1.86 | 65 | Palliative (P) | 2016-10-07 | 2016-10-07 | Oxaliplatin + Modified de Gramont | 02 | null | 300018003 | TRIAL |
| 300006696 | 300004786 | 1.68 | 73.9 | Curative (C) | 2015-08-04 | 2015-08-05 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300018023 | TRIAL |
| 300006697 | 300004786 | 1.6 | 56.8 | null | null | 2014-10-07 | FLUOROURACIL | 02 | N | 300018023 | CISPLATIN + FLUOROURACIL |
| 300006698 | 300004786 | 1.6 | 70 | Curative (C) | 2013-11-12 | 2013-11-28 | Cetuximab 7 day (>Cycle 2) | N | Y | 300018023 | CETUXIMAB |
| 300006699 | 300004786 | 1.62 | 0 | null | 2013-06-06 | 2013-06-09 | Carboplatin + Etoposide iv&po | 02 | N | 300018023 | CAPECITABINE |
| 300006700 | 300004787 | null | 81.6 | Palliative (P) | 2015-12-01 | 2016-01-12 | CISPLATIN + FLUOROURACIL | N | null | 300018682 | CISPLATIN |
| 300006701 | 300004788 | 1.7 | 72.6 | Neo-adjuvant (N) | 2013-11-14 | 2013-12-06 | PACLITAXEL | N | N | 300018695 | TRIAL |
| 300006702 | 300004789 | 1.78 | 52.8 | Curative (C) | 2014-08-30 | 2014-09-27 | Carboplatin + Cetux + FU (>Cycle 2) | 2 | N | 300019098 | CAPECITABINE + CARBOPLATIN |
| 300006703 | 300006988 | 1.6 | 94 | Palliative (P) | null | 2017-06-05 | GEMCITABINE + NAB PACLITAXEL | N | null | 300019215 | OXALIPLATIN + MDG |